Insurance coverage pathways *may* be slightly less restrictive than for injectable AOMs, but still highly variable and often require prior authorization
Featured in Drug Development & Delivery's Nasal & Inhalation eBook 2026, Dr
Prof Alexander Miras, an obesity expert at Ulster University who was not involved in the work, described the findings as very important, noting that while GLP-1s had been associated with improved functionality meaning it was easier to carry out everyday activities they had also been associated with a loss in muscle mass and strength
For tirzepatide (Mounjaro), the product information states that the incidence of nausea, diarrhoea and vomiting occurred primarily during dose escalation and decreased over time
The homogenate was centrifuged at 14,000 rpm for 10 min at 4 C, and the supernatant (850 L) was collected and transferred to Eppendorf tubes